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Abstract.  The protein C-protein S anticoagulant 
pathway is closely linked to the cndothelium. In this 
paper the synthesis and release of the vitamin K- 
dependent coagulation factor protein S is demon- 
strated. Western blotting, after SDS PAGE of Triton 
X-100 extracts of bovine aortic endothelial cells grown 
in serum-free medium, demonstrated the presence of 
protein S. A single major band was observed at Mr 
-75,000, closely migrating with protein S purified 
from plasma absent from cells treated with cyclohexi- 
mide. Metabolic labeling of endothelial cells with 
[35S]methionine confirmed de novo synthesis of pro- 
tein S. Using a radioimmunoassay, endothelium was 
found to release 180 fmol/105 cells per 24 h and con- 
tain 44 fmol/105 cells of protein S antigen. Protein S 
released from endothelium was functionally active 
and could promote activated protein C-mediated fac- 
tor 'Ca inactivation on the endothelial cell surface. 
Warfarin decreased secretion of protein S antigen by 
>90% and increased intracellular accumulation by al- 
most twofold. Morphological studies demonstrated in- 
tracellular protein S was in the Golgi complex, con- 
centrated at the trans face, rough endoplasmic reticu- 
lum, lysosomes, and in vesicles at the periphery. In 
contrast, protein S was not found in vascular fibro- 
blasts or smooth muscle cells. A pool of intracellular 
protein S could be released rapidly by the calcium 
ionophore A23187 (5 #M). This effect was dependent 
on the presence of calcium in the culture medium and 
could be blocked by LaCI3, which suggests that cyto- 
solic calcium flux may ~  responsible for protein S 
release. These results demonstrate that endothelial 
cells, but not the subendothelial cells of the vessel 
wall, can synthesize and release protein S, which indi- 
cates a new mechanism by which the inner lining of 
the vessel wall can contribute to the prevention of 
thrombotic events. 
p 
ROTEIN S is a regulatory vitamin K-dependent plasma 
protein, which is an essential component of the protein 
C anticoagulant  pathway (46). Protein S functions as a 
non-enzymatic  cofactor  which  promotes  binding  of  the 
enyzme-activated  protein C to membrane surfaces (46, 47). 
Once bound to a cellular or phospholipid  surface, activated 
protein  C  can  effectively exert  its  anticoagulant  function, 
inactivating  the cofactors, factors V, and VIII~, essential for 
the reactions  that lead to clot formation (18, 40, 47). The 
clinical significance of protein S is emphasized by the throm- 
boric diathesis observed in kindreds deficient in this coagula- 
tion factor (5, 7, 37). 
Recent studies have indicated  that the protein  C pathway 
is closely associated  with  the vessel wall. The activation  of 
protein  C by thrombin  is promoted by the presence of the 
endothelial  cell  membrane  protein  thrombomodulin  (10). 
Assembly of functional  activated  protein C-protein S com- 
plex also occurs effectively on the inner surface of the vessel 
wall (4). Formation of this complex requires binding of pro- 
tein S, which allows specific activated protein C-endothelial 
cell interaction  to occur. Furthermore,  cell-bound protein  S 
can  be cleared  from  the  cell  surface  by endocytosis  and 
degraded by a lysosomal-dependent  mechanism  (40). These 
findings suggest that endothelium is physiologically important 
in protein S function  and metabolism.  In terms of protein S 
synthesis, clinical  studies  have  demonstrated that although 
the level of the other vitamin  K-dependent coagulation  fac- 
tors is decreased by 50% in patients with liver disease, protein 
S is decreased by only 25% (2). The existence of extrahepatic 
sites of protein S synthesis could explain these findings. 
The close relationship  of protein  S to endothelium  led us 
to examine if protein  S is synthesized by endothelium.  The 
results of our study indicate that cultured  bovine aortic en- 
dothelial cells do synthesize and release functional protein S. 
Endogenous  protein  S is released either constitutively  or in 
response  to  stimulation  of endothelium  by an  agent  that 
induces cytosolic calcium flux. Synthesis and release of pro- 
tein  S by endothelium  is thus a new addition  to the list of 
mechanisms  through  which the vessel wall can regulate co- 
agulant events. 
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Cell Culture 
Bovine aortic endothelial ceils were  isolated  from calf aortas as described by 
Schwartz (36) and were grown in minimum essential medium that contained 
penicillin-streptomycin (50 U/ml -  50 #g/ml) and fetal bovine serum (10%; 
HyCIone Laboratories, Logan, UT). Cells were separated for subculture nonen- 
zymatically with  Dulbecco's phosphate-buffered saline (PBS)  (calcium- and 
magnesium-free)  that contained 10 mM sucrose and 1 mM EDTA. For exper- 
iments, cells (passages  4-10) from different aortas were grown to confluence in 
0.79-cm  2 wells (1.1-1.5 x  105 cells/cm2). Cultures were characterized as endo- 
thelial  by  morphological criteria (36),  the  formation of a  cobblestone-like 
monolayer with contact inhibition at confluence, and the presence of yon 
Willebrand factor antigen using indirect immunofluorescence  (20). 
24  h  after endothelial cells  achieved confluence they were  washed with 
Hanks' balanced salt solution (HBSS) t that contained 10 mg/ml dextran sulfate 
to elute surface bound protein S (40) and then placed in serum-free medium 
(minimum essential medium that contained penicillin-streptomycin [50 U/ml 
-  50 tag/roll,  10 mM Hepes [pH 7.4],  20 #g/ml transferrin [Sigma Chemical 
Co., St.  Louis, MO],  10 ug/ml insulin [Sigma Chemical Co.], and 5 mg/ml 
bovine serum albumin [BSA, Sigma Chemical Co.]).  Experiments were then 
done as described below. 
Coagulation Factors and Assays 
All purified coagulation factors were of bovine origin.  Purification of protein S 
was done as described (45).  Radiolabeling of protein S was accomplished by 
the lactoperoxidase method (8), using Enzymobeads according to the manufac- 
turer's instructions. The reaction was done at room temperature for 15 min by 
incubating Enzymobeads (50 ul; Bio-Rad Laboratories, Richmond, CA), pro- 
tein S (40 ~1; 29 ug), Na ~251 (2 mCi), and 2% glucose (20 ul). Free iodine was 
separated from protein S by gel filtration using a  column (1  ×  20 cm) of 
Sephadex G-25. The specific radioactivity of ~2~l-protein S was 9,000-12,000 
cpm/ng (corresponding to  ~0.1  tool  ~251 per  tool  of protein  S)  over  five 
radioiodinations. Radioiodinated protein S co-migrated  with unlabeled material 
on SDS PAGE. 
Protein C was purified as described previously (44). Protein C was activated 
by incubation with 5% thrombin (16) (wt/wt) for 3 h at 37"(7 in  1 mM Tris 
(pH 7.4), 0.I  M NaCI. The reaction mixture was adjusted to pH 6.5 with 4- 
morpholinoethanesulfonic acid and chromatographed on QAE-Sephadex (0.6 
x  5  cm) equilibrated with  5  mM 4-morpholinoethanesulfonic acid,  0.1  M 
NaCI. Activated protein C was eluted using a 0.1-0.6 M linear salt gradient (5 
ml/reservoir). Factor V, was purified by previously described methods (3), and 
the preparations used in this study were recombined from isolated subunits in 
the presence of 10 mM CaCI2 overnight at 4"C. Factors IX, X, and prothrombin 
were purified as described (14,  15, 28). Factor VII was generously provided by 
Dr.  W.  Kisiel (Department of Pathology, University of New Mexico, Albu- 
querque). 
Rabbit antisera to protein S were prepared as described by Vaitukaitis (43), 
and the lgG was isolated  by chromatography on DE52 (17); Affinity purified 
anti-protein S antibody was prepared using protein S imnlbbilized on affigel 
15 (2 mg of protein S/ml of resin; coupling was done by the manufacturer's 
protocol).  Total lgG (10 ml) was applied to the protein S-affigel 15 column 
(0.6  ×  15 cm) in 0.02 M Tris (pH 7.4) - 0.14 M NaCI, followed  by extensive 
washing of the column in 20 vol of the same buffer. Antibody to protein S was 
eluted using 0.2 M glycine (pH 2.5),  and then the lgG (1  mg) was dialyzed 
versus 0.02 M Tris (pH 7.4) - 0.14 M NaCI. This antibody did not react with 
the other vitamin K--dependent coagulation factors,  factors VII,  IX, X, pro- 
thrombin, and protein C in the radioimmunoassay described below. Western 
blotting, done as described below, after SDS PAGE of bovine plasma, demon- 
strated only a single band that co-migrated with purified protein S (data not 
shown). Monospecific rabbit antiserum to protein C was prepared as described 
above for protein S, and antiserum to prothrombin was generously provided 
by Dr. E. W. Davie (Department of Biochemistry, University of Washington, 
Seattle). Affinity purified goat anti-rabbit lgG (Pet-Freeze Biologicals, Rogers, 
AR) was radiolabeled  by the solid state lactoperoxidase technique as described 
above for protein S. 
Western blotting of endothelial cells for protein S was done after extensive 
washing of cells with HBSS. Cells were then incubated for 20 rain at 25"C with 
0.02 M Tris (pH 7.4), 0.1  M NaCI that contained 1% Nonidet P-40,  10 mM 
EDTA, 2 mM phenylmethylsulfonyl fluoride (Sigma Chemical Co.),  and 0.3 
mM leupeptin (Boehringer Mannheim Diagnostics, Inc., Houston, TX). Sam- 
pies were then prepared for electrophoresis (reduced SDS PAGE, 7.5%) by the 
1.  Abbreviation used in this paper.. HBSS, Hanks' balanced salt solution. 
method of Laemmli (24). Material from the gel was electrophoretically  trans- 
ferred to nitrocellulose paper, 0.45-urn pore size (Sehleieber  & Schuell,  Inc., 
Keene, NH), by a modification of the method of Towbin et at. (42). Electro- 
phoretie transfer was done for  12 h at 8.5"C and at constant power (13 W). 
Excess binding sites on the nitrocellulose  membrane were  blocked by a  2-h 
incubation at 37"C with 0.05  M  Tris (pH 7.4) - 0.1  M  NaCI that contained 
Carnation non-fat dry milk (22.7  g/8  oz of buffer)  (21).  Fresh buffer that 
contained milk and affinity purified anti-protein S (10 t~g/ml) or other anti- 
bodies (900 t~g/ml) was added for 2 more h at 37"C. Nitrocellulose  membranes 
were then washed over 1 h with four changes of 0.05 M Tris (pH 7.4), 0.15 M 
NaCI,  3 mM EDTA, and 0.05%  Tween. Finally,  buffer that contained milk 
and t251-affinity  purified anti-rabbit IgG (1.3 x  105 cpm/ml) was added for 2 
h  at  37"C. Blots were  washed as described above, dried,  and subjected to 
autoradiography at -80*(? using  Kodak X-Omat  (XAR 5) film (Eastman Kodak 
Co., Rochester, NY) and a Cronex intensifying  screen (DuPont Co., Wilming- 
ton, DE). Standard proteins, which included myosin heavy chain (Mr 200,000), 
phosphorylase B (Mr 97,400),  BSA (M, 68,000),  ovalbumin (Mr 43,000),  and 
a-chymotrypsin (M, 25,700) (Bethesda Research Laboratories,  Bethesda, MD), 
were run simultaneously. 
Endogenous labeling of endothelial cell protein S was done by maintaining 
cultures for 60 h  in methionine-free growth medium (Gibeo,  Grand Island, 
NY) that contained penicillin-streptomycin  (50 U/ml-50 tag/ml), 10 mM Hepes 
(pH 7.4), 20 t~g/ml transferrin, 10 ~g/ml insulin, and 5 mg/ml BSA supple- 
merited with [35S]methionine  (20 #Ci/ml;  1,340 Ci/mmol Amersham Corp., 
Arlington Heights, IL). Culture supernatants  were harvested and inhibitors were 
added: EDTA (1 mM), phenylmethylsulfonyl  fluoride  (2 mM), leupeptin (0.3 
mM). After centrifugation at liP g for 20 min, protein A-Sepharose (Pharmacia 
Fine Chemicals, Piscataway,  NJ) was added (30% by volume) to the superna- 
tants for 30 rain at room temperature. The mixture was again eentrifuged (103 
g for 5 rain) and either affinity purified rabbit anti-bovine protein S (10 ~g/ 
ml) or rabbit anti-bovine protein C (20 ~g/ml) was added for 18 h at 4"C. The 
next morning, protein A-Sepharose (20% by volume) was added for 30 min at 
room temperature and the mixture was centrifuged (103 g  for 5 rain).  After 
centrifugation, the pellet was washed throe times (20 rain/wash) with 50 mM 
Tris/HCl (pH 7.4), 0.1 M NaCI, and finally resuspended in 0.1 ml of 5% SDS, 
25 mM Tris/HCI (pH 6.8),  10%  2-mercaptoethanol. The resuspended pellet 
was incubated at  100*C for 3 rain and then samples were prepared for SDS 
PAGE (7.5%) by the method of Laemmli (24). Autoradiography was done as 
described above. Molecular weights were  interpolated from semilogarithmic 
plots based on the migration of standard proteins (same as described  above) 
run simultaneously. 
Radioimmunoassay for protein S antigen was done by the general method 
described by Suzuki and Thompson (41) using staphylococcal  protein A (En- 
zyme Center, Boston, MA) in place of  a second antibody. The limit of detection 
in this assay  was 100 pM protein S antigen, which corresponded to 80% binding 
on the standard curve. When necessary, samples for protein S determination 
were concentrated ~ 10-fold before assays. Competition studies using this assay 
indicated no inhibition of ~251-protein S--antibody  binding in the presence of 
factors VII,  IX,  X,  protein C,  or prothrombin when each was added at a 
concentration of 100 gg/ml. Kadioimmunoassays  were also done which com- 
pared the inhibition of ~2Sl-protein S-antibody binding by purified protein S, 
normal bovine plasma, and bovine plasma from animals treated with dicou- 
marol. Dicoumarol plasma was prepared from cows treated with dicoumarol 
(1 g/d) for 10 d (30). Functional levels of factor X and protein S were <8% 
and <5%, respectively, based on coagulant assays  (1, 7). The antibody to bovine 
protein S recognized protein S in the plasma of dicoumarol-treated cows as 
well as fully ~,-carboxylated protein S since inhibition of ~251-protein  S-antibody 
binding by dilutions of dicoumarol-treated and normal plasma occurred in 
parallel  and with  the same slope.  Hence, this assay could be  used in  the 
experiments where warfarin is added to the culture medium. 
Before experiments were done to assess release of protein S from endothe- 
lium, monolayers were rinsed briefly with dextran sulfate (10 mg/ml)-contain- 
ing buffer. Dextran sulfate has been shown to remove surface-bound protein S 
(40), although it did not affect the viability  of the monolayer based on trypan 
blue exclusion (>90%) or morphological criteria. 
Activated protein C-protein S-mediated factor V, inactivation on the en- 
dothelial  cell surface was done as described previously (40). First endothelial 
cell monolayers  were washed with dextran sulfate (10 mg/ml)--containing  HBSS 
and then 0.35 ml of 10 mM Hepes (pH 7.45) that contained 137 mM NaCI, 4 
mM KCI,  11  mM glucose, 3  mM CaCI2, and  1 mg/ml BSA  was added. 
Monolayers were incubated at 37"C, and at the indicated times factor V, (80 
nM) and activated protein C  (1  nM) were  added. Where indicated, affinity 
purified antibody to protein S (50 ~g/ml) was also present. The reaction mixture 
was incubated at room temperature with constant gentle mixing, and one 25- 
#1 aliquot was removed from each well at  10, 30, 40, 60,  90, and  120 s of 
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(22) by adding 25 ~1 of diluted sample to 25 ~1 buffer (0.05  M Tris [pH 7.5], 
0. I M NaCI,  1 mg/ml BSA), 50 #I rabbit brain thromboplastin (Dade, Puerto 
Rico),  and 50 ul CaCI2 (25  raM). Finally,  50 al of factor V-deficient human 
plasma (30) was added and the clotting time determined. Standard curves were 
constructed using  purified factor V, and all clotting times  were done in duplicate 
or triplicate.  The rate of factor V, inactivation was determined from the slope 
of  the linear initial portion of  a plot of  factor V, activity versus  incubation time 
and generally included the  10-, 30-,  40-,  and 60-s points. In the presence of 
exogenous protein S (5  riM), the maximal rate of factor V. inactivation was 
0.19 nM/s (0.03  pmol/10  s cells). 
lonophore-induced Release of  Protein S 
from Endothelial Cells 
After 5 d in serum-free medium, endothelial cells were rinsed with HBSS that 
contained dextran sulfate (10 mg/ml) and then 0.35 ml of 10 mM Hepes (pH 
7.45),  137 mM NaCI,  4  mM KC1, 11  mM glucose, 3 mM CaClx was added 
along with the indicated concentration of ionophore, lonophore A23187 (Cal- 
biochem-Behring Corp., La Jolla, CA) was prepared as a  1 mM stock solution 
in absolute ethanol, ionomycin (Calbiochem-Behring  Corp.) was prepared as a 
stock solution of 1 mM in  acetone, and valinomycin (Calbiochem-Behring 
Corp.) was prepared as a stock solution of 2 mM in acetone. In each case the 
ionophore was diluted such that the final concentration of organic solvent was 
_<-0.01%. This concentration of  ethanol or acetone had no effect on endothelial 
cell protein S release in the absence ofionophore. After addition of  an ionophore 
to cell cultures, samples  were obtained at the indicated times for determination 
of protein S  antigen by radioimmunoassay. Only one sample was removed 
from each well. 
Immunolocalization  of  Protein S 
Immunofluorescence  studies were done as follows: cell monolayers  were grown 
on coverslips, washed extensively  with HBSS, fixed for 1-2 min with paraform- 
aldehyde (3.5%)  in PBS-0.1%  Nonidet P-40, washed in PBS, and fixed for an 
additional 5 min with 3.5%  paraformaldehyde. Washed coverslips were incu- 
bated with affinity purified rabbit antibody to bovine protein S, and sites of 
binding of primary antibody were visualized with fluoreseein-conjugated  goat 
anti-rabbit immunoglobulin (Cappel Laboratories, Cochranville, PA). Stained 
coverslips were mounted in Gelvatol that contained 1 mg/ml p-phenylenedia- 
mine and examined in a  Leitz Dialux 20 microscope with a  2.4 Ploempak 
filter  block and water immersion fluorite objectives and recorded on Kodak 
Tri-X  film. Controls included substitution of preimmune rabbit  serum for 
specific immunoglobulin  and exposure to secondary (fluorochromed) antibody 
alone. Monolayers not permeabilized with aid of detergent also failed to stain 
(these monolayers  were washed extensively resulting in removal of  any surface- 
bound protein S). 
Monolayers grown in  35-mm dishes were  used for electron microscopic 
studies. Monolayers were fixed for 1-2 min with 2% paraformaldehyde in PBS, 
permeabilized for  1 min with 3.5%  paraformaldehyde in PBS that contained 
0.1% Saponin, washed briefly in PBS, and fixed further for 10 min with 3.5% 
paraformaldehyde. All solutions contained 3% sucrose. After fixation, mono- 
layers were incubated with affinity purified rabbit anti-protein S IgG diluted 
in PBS that contained 0.1% BSA overnight at 4"C. Sites of primary antibody 
were visualized with biotinylated goat anti-rabbit immunoglobulin and horse- 
radish peroxidase--conjugated avidin (Vectastain, Vector Laboratories, Burlin- 
game, CA). The enzyme was revealed with 0.01% hydrogen peroxide and 0.5% 
diaminobenzidine in 0.2 M Tris buffer pH 7.4. After reaction product had been 
developed, monolayers were postfixed for 30 min with 2.5% glutaraldehyde in 
0.1 M cacodylate buffer, pH 7.2, with 3% sucrose and again for 30 min in 2% 
OsO4 in cacodylate buffer for 30 min, block-stained in 0.25% aqueous uranyl 
acetate for 1 h, dehydrated, and embedded flat in Epon 812. Thin-sections  (cut 
with the DuPont-Sorvall MT6000 microtome) were examined in a Philips 200 
electron  microscope. Inclusion of glutaraldehyde even at 0.1%  in  the first 
fixation and permeabilization steps sharply reduced antibody binding or pene- 
tration even after blockade of free aldehyde. 
Results 
Confluent endothelial cells incubated for 6  d  in  serum-free 
medium contained protein S, as shown by Western blotting 
of cell extracts after reduced SDS PAGE in which a  double 
antibody technique was used to visualize protein S (Fig.  1). 
Autoradiograms of the  Western  blots demonstrate a  single 
Figure  1.  Western  blotting  of endothelial  cell  extracts.  Confluent 
endothelial cell monolayers (passage 1) were washed with HBSS and 
maintained in serum-free medium for 4 d. Then either cycloheximide 
(2 #g/ml) was added or no further addition was made for the following 
48 h. Cells were washed with HBSS and solubilized with Nonidet P- 
40  (1%).  After reduced  SDS  PAGE  (7.5%),  Western blotting  was 
done and immunoreactive material was visualized using first a mon- 
ospecific  rabbit  antibody  to  the  indicated  coagulation  factor  and 
second an affinity purified  ~2~l-goat anti-rabbit  IgG.  Details of the 
procedure  are  described  under  Materials  and  Methods.  Lane  A, 
endothelial cells incubated with cycloheximide; affinity purified an- 
tibody to  protein  S  used in the first stage; lane B,  endothelial cells 
incubated without cycloheximide; affinity purified antibody to pro- 
tein  S  used in  first stage; lane C,  purified  protein  S  from  plasma; 
affinity purified antibody to protein S used in the first stage; lane D, 
endothelial  cells  incubated  without  cycloheximide;  anti-protein  C 
IgG used in the first stage; lane E, endothelial cells incubated without 
cycloheximide; anti-prothrombin IgG used in the first stage. 
major band, Mr ~75,000,  which co-migrates with protein S 
purified  from  bovine  plasma  (Fig.  1,  lanes  B  and  C).  To 
determine whether endothelial cell protein synthesis was re- 
quired to generate  this protein S,  cycloheximide  (2  ug/ml) 
was added to cultures for 48 h. Although this dose of cyclo- 
heximide did not reduce cell viability in the cultures, based 
on trypan blue exclusion and morphology of the monolayers, 
protein S was no longer apparent on the autoradiograms (Fig. 
1, lane A). The possibility that endothelial cells could synthe- 
size  protein  S  de  novo  led  us  to  examine  cultures  for the 
presence of protein C and prothrombin antigen. Substitution 
of monospecific  rabbit  IgG  directed  against  protein  C  or 
prothrombin for the anti-protein S antibody did not reveal 
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tration of the samples (Fig. l, lanes D and E). To confirm the 
Western  blotting results,  endothelial  cells were labeled with 
[35S]methionine and supernatants  were  subjected to immu- 
noprecipitation (Fig. 2). Autoradiograms demonstrated a sin- 
Figure  2.  Autoradiogram  of gel  that  contained 
immunoprecipitated  [35S]methionine-labeled pro- 
teins released into the medium by bovine  aortic 
endothelial  cells. Monolayers  were  incubated  in 
[35S]methionine-containing medium for 60 h and 
immunoprecipitated  with  antibody  to protein  S 
(lane A) or protein C (lane B). Immunoprecipitates 
were subjected to reduced SDS PAGE (7.5%) and 
autoradiography  was done.  Details of the proce- 
dure are described under Materials and Methods. 
gle major band, Mr ~74,000, when immunoprecipitation used 
antibody to protein S (lane A) but no bands when antibody 
to protein C, another vitamin K-dependent coagulation pro- 
tein, was used (lane B). These findings indicate that cultured 
bovine aortic endothelial cells synthesize the coagulation fac- 
tor protein S. 
Since endothelial cell protein S is physiologically significant 
in hemostasis only after release  from the intracellular pool, 
secretion  of protein  S  antigen  was  studied  (Fig.  3).  After 
endothelial cells were maintained in serum-free medium for 
3 d, protein S was eluted from the cell surface using dextran 
sulfate (10 mg/ml) (40), and monolayers were then incubated 
in serum-free medium.  Protein  S was steadily released  into 
the culture  fluid (Fig.  3A). Supplementation  of culture me- 
dium with vitamin K (25 #g/ml) led to an increase in protein 
S  release  with  a  small  decrease  in  the pool  of intracellular 
protein S (Fig. 3 B). The warfarin derivative 3(a-acetonylben- 
zyl)-4-hydroxycoumarin (1  #g/ml),  in contrast, dramatically 
decreased protein S release with an increase in the intracellular 
pool. These results are consistent with previous studies show- 
ing that defective 7-carboxylation of vitamin  K-dependent 
coagulation  proteins  leads  to  defective  cellular  release  (l l, 
29).  Addition  of cycloheximide to  cultures  decreased  both 
protein S release and the amount of intracellular protein S, as 
predicted from the results shown in Fig.  1. 
Activated  protein  C  and  protein  S  can  interact  on  the 
surface  of bovine  aortic  endothelial  cells,  which  results  in 
considerable  acceleration  of activated  protein  C-mediated 
factor Va inactivation (40). This led us to study the functional 
significance of protein S released from endothelium in terms 
of an  increase in the rate of factor Va inactivation  (Fig. 4). 
After 3 d in serum-free medium, surface-bound protein S was 
eluted  and  endothelial  cells  were  incubated  in  serum-free 
medium for the times indicated in Fig. 4. The capacity of the 
endothelial  cell  surface  to  accelerate  activated  protein  C- 
dependent factor Va inactivation was then assessed using low 
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Figure 3. Protein  S released from 
and remaining associated with en- 
dothelial  cells. (.4) Released pro- 
tein  S. Confluent  endothelial  cell 
monolayers  (passage  2)  main- 
tained in serum-free medium were 
washed  with  dextran  sulfate  (10 
mg/ml)-containing  HBSS  and 
then incubated  in serum-free me- 
dium alone (O), or supplemented 
with  either  cycloheximide (2 #g/ 
ml)  (A), vitamin  K  (25  #g/ml, 
Aqua  Mephyton,  Merck,  Sharp 
and Dohme, West Point, PA) (O), 
or the warfarin derivative 3(a-ace- 
tonyl  benzyl)-4-hydroxycoumarin 
(1  vg/ml,  Sigma  Chemical  Co.) 
(x).  Aliquots of supernatant  were 
taken  at the indicated  times  and 
assayed for protein S antigen. The 
mean of duplicates is shown. (B) Intracellular protein S. After removal of the culture medium at 72 h (see A above), monolayers were washed 
once in dextran sulfate (l0 mg/ml)-containing  HBSS and solubilized with 1% Nonidet P-40. The radioimmunoassay  for protein S antigen was 
then done. O, endothelial cells maintained  in serum-free medium.  W, endothelial cells maintained  in serum-free medium that contained the 
warfarin derivative  used in A (l  ~g/ml).  K, endothelial  cells maintained  in serum-free medium that contained  vitamin  K  (25 ~g/ml).  C, 
endothelial cells maintained  in serum-free medium that contained  cycloheximide. The mean and SEM are shown (n =  7). In both A and B 
above, details of the experimental procedure are described under Materials and Methods. 
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independent  factor "Ca inactivation.  During  the  incubation 
period, the capacity of  the endothelial cell surface to accelerate 
the rate of factor V, inactivation rose. This was due to the 
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Figure 4. Promotion  of activated  protein  C-mediated  factor  II, in- 
activation by protein S from endothelial cells. Confluent endothelial 
cell monolayers (passage 1) maintained in serum-free medium for 3 
d were washed with dextran sulfate (10 mg/ml)-containing HBSS and 
incubated in 10 mM Hepes (pH 7.45) that contained 137 mM NaC1, 
4 mM KCI, 11 mM glucose, 3 mM CaCI:, 1 mg/ml BSA (e). Where 
specified, affinity purified anti-protein  S lgG was present (50 tzg/ml) 
(x). At the indicated times factor Va (80 nM) and activated protein 
C (1  nM) were added, and the rate of factor  Vo inactivation was 
assessed. Nonimmune IgG (50 ~g/ml) had no effect on the rate of 
factor V. inactivation. The mean of duplicates is shown and details 
of the  experimental procedure are described under  Materials and 
Methods. 
presence  of endothelial  cell  protein  S,  as  indicated  by its 
decrease to baseline in cultures that contained affinity purified 
anti-protein S  IgG. Cultures maintained in the presence of 
3(a-acetonyl benzyl)-4-hydroxycoumarin did  not  show  en- 
hanced capacity of the endothelial cell surface to accelerate 
the rates of activated protein C--dependent factor "Ca inacti- 
vation (data not shown). Thus, protein S derived from endo- 
thelial cells maintained in normal growth medium can asso- 
ciate with the cell surface and, in the presence of activated 
protein C, promote factor "Ca inactivation. 
To complement the biochemical studies presented thus far, 
intracellular sites of protein S were visualized immunocyto- 
logically (Figs.  5  and  6).  Immunofluoreseence microscopy 
showed endothelial cell protein S to be concentrated in the 
Golgi complex with some additional fine punctate deposits in 
the peripheral cytoplasm of many of the cells (Fig. 5 a). After 
addition  of cycloheximide to  cultures,  immunofluorescent 
staining ofintracellular protein S was greatly diminished (Fig. 
5 b). In contrast to endothelium, vascular smooth muscle cells 
and fibroblasts had almost no immunocytologicaUy demon- 
strable antigen (data not shown) consistent with their much 
smaller protein S content. At the resolution of the electron 
microscope, protein S, demonstrable by immunoperoxidase 
staining,  was identified  intralumenally in  cisterns of rough 
endoplasmic reticulum (Fig.  6a),  in occasional distal stacks 
at the concave trans face of the Golgi apparatus (Fig. 6 b), and 
in  adjacent vesicles.  Protein  S was also evident within  30- 
120-nm vesicles at the periphery, near the cell cortex, some 
of these in apparent process of fusion (Fig. 6 c). 
The presence of protein  S  within  endothelium  suggested 
the possibility of a mechanism for its rapid release in response 
to perturbations. By analogy with the von Willebrand factor 
(16,  26),  we considered whether elevation of endothelial cell 
cytosolic calcium might mediate protein S release. Incubation 
Figure 5. Immunofluorescent localization of  protein S in cultured bovine aortic endothelial cells. (a) In normal, untreated cells there is a finely 
punetate to granular endoplasmic distribution, and an apparent concentration in the juxtanuclear Golgi region. (b) Little or no staining is 
observed in cells that have been treated with 2 t~g/ml eycloheximide for 48 h, (c) Monolayers treated with the calcium ionophore A23187 
(5 ~M) demonstrate a reduction of fluorescence intensity, especially  in the perinuclear area corresponding to the Golgi region. Bar, 10 ~m. 
Stern et al. Synthesis and Release of  Protein S  19  7 5 Figure 6. Immunolocalization of protein S in endothelial cells in the electron microscope visualized with indirect biotin-avidin-horseradish 
peroxidase method (see Materials and Methods). Many cisternae of endoplasmic reticulum contain reaction product, i.e., protein S, but some 
are not stained (arrowhead, a). Protein S is also localized within a few lamellar stacks at the concave trans face of the Golgi complex, and in 
small vesicles associated with them (b). In the subcortical endoplasm of most cells there are many small (60-100 rim) horseradish-peroxidase- 
positive (i.e., protein S--containing) vesicles, some of them in process of fusion (c). Bar, 300 nm. 
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Figure  7.  Time  course  of ionophore  A23187-induced  protein  S 
release from endothelial cells. Confluent endothelial cell monolayers 
(passage  2) maintained in serum-free medium for 3 d  were washed 
with dextran sulfate (10 mg/ml)-containing HBSS and then 0.35 ml 
of 10 mM Hepes (pH 7.45) that  contained  137  mM NaC1,  4  mM 
KCI, 11  mM glucose, 3 mM CaC12, 1 mg/ml BSA was added in the 
presence (e)  or absence  (©)  of ionophore A23187  (5  t~M). At the 
indicated times aliquots of supernatant were removed for protein S 
radioimmunoassay. The mean of duplicates is shown. 
Table L  The Effect of  lonophores on Endothelial Cell 
Protein S Release* 
lonophore added  Final concentration  Protein S released 
#n  fmol/lO' cells 
Ionophore A23187  5  26 +  5 
1  20+4 
Ionomycin  10  19 _  4 
Valinomycin  10  2 +  1 
No addition  0  3 +  1 
* Confluent endothelial cell monolayers (passage 3) maintained in serum-free 
medium for 3 d were washed with dextran sulfate (10 mg/ml)-containing HBSS 
and then 0.35 ml of 10 mM Hepes (pH 7.45) that contained 137 mM NaCI, 4 
mM KCI, 11 mM glucose, 3 mM CaCI2, 1 mg/ml BSA was added alone or in 
the presence of the indicated concentration of ionophore. Aliquots of super- 
natant were assayed for protein S antigen after 5 rain and the mean and SEM 
are shown (n =  1  I). 
of endothelium with low concentrations  of the calcium ion- 
ophore  A23187  (4)  resulted  in  rapid  release  of  protein  S 
antigen into the culture medium (Fig. 7, Table I). In contrast 
to A23187-induced release of the von Willebrand factor (26), 
which continues beyond 30 rain, protein S secretion is maxi- 
mal  by  5  rain.  Approximately  50%  of  total  intracellular 
protein  S  is in this  rapidly  releasable  pool.  Consistent  with 
these  findings,  protein  S  immunofluorescence  studies  dem- 
onstrated an apparent reduction in fluorescence intensity after 
exposure of endothelium to A23187  (Fig. 5 c). Similar to the 
The Journal of Cell Biology,  Volume 102, 1986  1976 Table II. Calcium Dependence of  lonophore A23187- 
induced Endothelial  Cell Protein S Release* 
lonophore 
A23187 (5  gM)  Other  addition  Protein  S released 
fmol/lO s cells 
+  0  5-+1 
+  CaCl2 (0.01 mM)  6 -+ 1 
+  CaCI2 (0.1 mM)  10 _+ 2 
+  CaCI2 (3.0 raM)  23 _+ 4 
+  CaCl2 (3.0 mM) + LaCl3 (lO aM)  6 -+ l 
0  0  4-+1 
* Confluent  endothelial  cell monolayers (passage 3) maintained  in serum-free 
medium for 3 d were washed with dextran sulfate (10 mg/ml)-containing  HBSS 
and then 0.35 ml of 10 mM Hepes (pH 7.45) that contained  137 mM NaCI, 4 
raM KCI, 11 mM glucose was added alone, or in the presence of  the ionophore 
A23187 (5 #M) and the indicated amount of calcium chloride or lanthanum 
chloride. Aliquots ofsupematant were assayed for protein S antigen after 5 rain 
and the mean and SEM are shown (n = 8). 
release of von Willebrand factor from endothelium (16, 26), 
protein S release is dependent on the presence of calcium in 
the medium (Table II). Inclusion of lanthanum chloride (10 
zM), an antagonist of calcium influx (34, 38) also prevents 
A23187-stimulated release of protein S (Table II).  Further 
evidence that  A23187-induced  release of protein S  was  a 
specific effect mediated by calcium is suggested by the finding 
that  ionomycin, another calcium  ionophore (23),  but  not 
valinomycin, a potassium ionophore (33), induced protein S 
secretion (Table I). 
Discussion 
The first suggestion that endothelium might elaborate func- 
tional protein S occurred during studies of assembly of acti- 
vated protein C-protein S on the endothelial cell surface (40). 
During prolonged incubation of endothelial cells in serum- 
free medium, the rate of activated protein C-mediated factor 
V~ inactivation steadily increased in the absence of exogenous 
protein S.  When  subsequent experiments showed that this 
acceleration of factor V~ inactivation could be blocked by 
antibody to protein S, this suggested production of protein S 
by endothelium. The results presented in this paper demon- 
strate that protein S is synthesized by cultured bovine aortic 
endothelial cells.  The subcellular distribution  of protein S 
antigen is like that of other proteins produced and secreted 
by cells. Thus, in addition to promoting the formation and 
function of activated protein C, endothelial cells also synthe- 
size the cofactor, protein S, necessary for expression of acti- 
vated protein C anticoagulant activity. For an average person 
having a blood volume of 5 liters and -1012 endothelial cells 
(49), the rates of synthesis observed in this study would result 
in the production of 10 zg/ml per d of protein S. The total 
plasma concentration of protein S, 20 tzg/ml (2), may thus be 
accounted  for at  least  in  part  by endothelial cell--derived 
protein  S.  Preliminary results  have  indicated  that  bovine 
adrenal capillary and human umbilical vein endothelial cells 
also synthesize protein S, which suggests that this may be a 
general  property of endothelial cells.  Studies by Fair  and 
colleagues (13) have also demonstrated that human endothe- 
lial cells synthesize protein S. The rates of protein S synthesis 
by these different types of endothelium, however, remain to 
be determined. 
Traditionally, hepatocytes have been felt to be the major 
source of vitamin K-dependent coagulation proteins, which 
include protein S (11,  12,  16). The synthesis of protein S by 
endothelium,  coupled with  the  previous demonstration  of 
factor VII synthesis by monocyte (6, 3 I), indicates that extra- 
hepatic sites may be involved in controlling the plasma levels 
of these vitamin K--dependent proteins. At least two separate 
results suggest  that endothelium contains  the  vitamin  K- 
dependent  carboxylase necessary  for  the  posttranslational 
modifications required for expression of protein S function. 
First, protein S synthesized by endothelium is functionally 
active (Fig. 4). Second, a vitamin K antagonist blocks secre- 
tion (Fig.  3), and the protein found in the presence of the 
antagonist lacks functional activity. In this context the pres- 
ence of a  vitamin K--dependent carboxylase system in the 
vessel wall may explain the presence of 7-carboxyglutamic- 
containing proteins in calcified atherosclerotic plaques (25), 
Release of plasminogen activators (27)  and  prostacyclin 
(48) have been considered integral components of the anti- 
coagulant nature of the vessel wall. Rapid release of protein 
S from endothelium would provide another mechanism by 
which the vessel wall can potentially respond to perturbation 
with  an  increase in  its antithrombotic potential. Although 
physiological effectors of protein S release remain to be elu- 
cidated, the link between intracellular calcium flux and secre- 
tion of  protein S, as suggested by the ionomycin and A23187 
data, implies a similarity to the mechanism ofvon Willebrand 
factor release from endothelium (16,  26).  In the latter case, 
elevation ofcytosolic  calcium directly by A23187 or indirectly 
by  thrombin,  via  phospholipid  methylation,  leads  to  von 
Willebrand  factor secretion (16).  Studies are  underway to 
compare the mechanism of protein S release with this model. 
The presence of protein S within endothelium suggests that it 
may be involved in other activated protein C-mediated cel- 
lular phenomena, such as activated protein C-mediated alter- 
ation of endothelial cell fibrinolytic activity (19, 35). 
Synthesis of protein S by endothelium indicates another 
aspect of the protein C anticoagulant pathway in which the 
vessel wall plays a central role. This represents a final step in 
a  protein S-endothelial cell cycle which is quite unique in 
coagulation: protein S can be synthesized and released by 
endothelium, it can function on the endothelial cell surface, 
and finally be cleared from the cell surface by an endocytotic 
mechanism that results in its degradation (39). 
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